序号 |
股票代码 |
股票名称 |
机构名称 |
变动方向 |
变动股份数(股) |
变动后数量(股) |
变动后持股率 |
公布日期 |
1 |
UBS Group AG |
减持 |
-846.41万 |
44305.78万 |
11.78% |
2024-07-02 |
||
2 |
UBS Group AG |
减持 |
-568.19万 |
48466.24万 |
12.88% |
2024-06-12 |
||
3 |
UBS Group AG |
增持 |
619.45万 |
49211.61万 |
13.08% |
2024-06-11 |
||
4 |
UBS Group AG |
减持 |
-1065.45万 |
48592.86万 |
12.92% |
2024-06-10 |
||
5 |
UBS Group AG |
增持 |
3815.18万 |
49689.94万 |
13.21% |
2024-06-07 |
||
6 |
UBS Group AG |
增持 |
356.95万 |
45287.88万 |
12.04% |
2024-05-02 |
||
7 |
UBS Group AG |
减持 |
-1443.97万 |
44096.64万 |
11.72% |
2024-04-30 |
||
8 |
UBS Group AG |
增持 |
3198.70万 |
48300.56万 |
12.84% |
2024-04-15 |
||
9 |
UBS Group AG |
减持 |
-2285.48万 |
44930.41万 |
11.94% |
2024-04-12 |
||
10 |
UBS Group AG |
减持 |
-1616.05万 |
47298.11万 |
12.57% |
2024-04-10 |
||
11 |
Shorea LBG |
减持 |
-854.40万 |
19231.79万 |
5.11% |
2024-04-10 |
||
12 |
Nelumbo Investments Limited |
减持 |
-854.40万 |
19231.79万 |
5.11% |
2024-04-10 |
||
13 |
LuYe Pharmaceutical Investment Co., Ltd. |
减持 |
-854.40万 |
19231.79万 |
5.11% |
2024-04-10 |
||
14 |
LuYe Pharmaceutical International Co., Ltd. |
减持 |
-854.40万 |
19231.79万 |
5.11% |
2024-04-10 |
||
15 |
Luye Pharma Holdings Ltd. |
减持 |
-854.40万 |
19231.79万 |
5.11% |
2024-04-10 |
||
16 |
Luye Life Sciences Group Ltd |
减持 |
-854.40万 |
19231.79万 |
5.11% |
2024-04-10 |
||
17 |
Ginkgo (PTC) Limited |
减持 |
-854.40万 |
19231.79万 |
5.11% |
2024-04-10 |
||
18 |
UBS Group AG |
增持 |
339.29万 |
48914.31万 |
13.00% |
2024-04-09 |
||
19 |
UBS Group AG |
减持 |
-631.65万 |
48371.81万 |
12.86% |
2024-04-04 |
||
20 |
UBS Group AG |
增持 |
631.65万 |
49152.26万 |
13.07% |
2024-04-02 |
||
21 |
UBS Group AG |
减持 |
-631.65万 |
48371.12万 |
12.86% |
2024-03-29 |
||
22 |
UBS Group AG |
增持 |
970.94万 |
49690.43万 |
13.21% |
2024-03-26 |
||
23 |
UBS Group AG |
减持 |
-413.54万 |
48542.27万 |
12.90% |
2024-03-25 |
||
24 |
UBS Group AG |
增持 |
74.25万 |
48956.16万 |
13.01% |
2024-03-22 |
||
25 |
UBS Group AG |
减持 |
-970.94万 |
48211.92万 |
12.82% |
2024-03-20 |
||
26 |
UBS Group AG |
增持 |
631.65万 |
49444.91万 |
13.14% |
2024-03-19 |
||
27 |
UBS Group AG |
减持 |
-631.65万 |
48801.81万 |
12.97% |
2024-03-18 |
||
28 |
UBS Group AG |
增持 |
631.65万 |
49045.32万 |
13.04% |
2024-03-15 |
||
29 |
UBS Group AG |
减持 |
-88.05万 |
52583.10万 |
13.98% |
2024-01-16 |
||
30 |
Ginkgo (PTC) Limited |
增持 |
200.00万 |
125919.67万 |
33.47% |
2024-01-12 |
||
31 |
Shorea LBG |
增持 |
200.00万 |
125919.67万 |
33.47% |
2024-01-12 |
||
32 |
Nelumbo Investments Limited |
增持 |
200.00万 |
125919.67万 |
33.47% |
2024-01-12 |
||
33 |
LuYe Pharmaceutical Investment Co., Ltd. |
增持 |
200.00万 |
125919.67万 |
33.47% |
2024-01-12 |
||
34 |
LuYe Pharmaceutical International Co., Ltd. |
增持 |
200.00万 |
125919.67万 |
33.47% |
2024-01-12 |
||
35 |
Luye Pharma Holdings Ltd. |
增持 |
200.00万 |
125919.67万 |
33.47% |
2024-01-12 |
||
36 |
Luye Life Sciences Group Ltd |
增持 |
200.00万 |
125919.67万 |
33.47% |
2024-01-12 |
||
37 |
UBS Group AG |
减持 |
-881.94万 |
51848.31万 |
13.78% |
2023-12-13 |
||
38 |
UBS Group AG |
减持 |
-1392.71万 |
52131.37万 |
13.86% |
2023-12-05 |
||
39 |
UBS Group AG |
减持 |
-1392.71万 |
52131.37万 |
10.81% |
2023-12-05 |
||
40 |
易方达基金管理有限公司 |
减持 |
-323.10万 |
18478.75万 |
4.91% |
2023-08-10 |
||
41 |
UBS Group AG |
增持 |
1740.91万 |
57140.45万 |
15.19% |
2023-07-25 |
||
42 |
UBS Group AG |
减持 |
-2246.17万 |
54247.59万 |
14.42% |
2023-07-14 |
||
43 |
UBS Group AG |
增持 |
2727.49万 |
56973.65万 |
15.15% |
2023-07-11 |
||
44 |
UBS Group AG |
增持 |
1.37亿 |
54269.46万 |
14.43% |
2023-07-10 |
||
45 |
UBS Group AG |
减持 |
-825.30万 |
40937.34万 |
10.88% |
2023-07-03 |
||
46 |
UBS Group AG |
减持 |
-6875.00万 |
41401.71万 |
11.01% |
2023-06-30 |
||
47 |
UBS Group AG |
增持 |
3.01亿 |
47779.78万 |
12.70% |
2023-06-28 |
||
48 |
UBS Group AG |
增持 |
2.19亿 |
36564.79万 |
9.72% |
2023-06-28 |
||
49 |
易方达基金管理有限公司 |
增持 |
663.10万 |
19274.60万 |
5.12% |
2023-06-28 |
||
50 |
Ginkgo (PTC) Limited |
减持 |
-2.60亿 |
125719.67万 |
38.70% |
2021-02-02 |
数据来源：东方财富Choice数据